| Literature DB >> 26975705 |
Masato Kajikawa1, Tatsuya Maruhashi1, Eisuke Hida1, Yumiko Iwamoto1, Takeshi Matsumoto1, Akimichi Iwamoto1, Nozomu Oda1, Shinji Kishimoto1, Shogo Matsui1, Takayuki Hidaka1, Yasuki Kihara1, Kazuaki Chayama1, Chikara Goto1, Yoshiki Aibara1, Ayumu Nakashima1, Kensuke Noma1, Yukihito Higashi2.
Abstract
UNLABELLED: Measurement of nitroglycerine-induced vasodilation has been performed to differentiate endothelium-dependent vasodilation from endothelium-independent vasodilation as a control test for flow-mediated vasodilation (FMD). Recently, nitroglycerine-induced vasodilation per se has been reported to be a useful marker of the grade of atherosclerosis. The present study aimed to evaluate the prognostic value of FMD combined with nitroglycerine-induced vasodilation for future cardiovascular events. We measured FMD and nitroglycerine-induced vasodilation in 402 subjects, including patients with cardiovascular diseases. During a median follow-up period of 32.3 months, 38 first major cardiovascular events (death from cardiovascular causes, acute myocardial infarction, stroke, and coronary revascularization) occurred. Receiver-operator characteristic curve analysis revealed that FMD alone and nitroglycerine-induced vasodilation alone can predict cardiovascular events with areas under the curve of 0.671 (cutoff 3.3%) and 0.692 (cutoff 11.6%), respectively. FMD combined with nitroglycerine-induced vasodilation predicts cardiovascular events with an area under the curve of 0.701. After adjustment for age, sex, and cardiovascular risk factors, above cutoff FMD (≥3.3%) and below cutoff nitroglycerine-induced vasodilation (<11.6%; hazard ratio, 5.55; 95% confidence interval, 1.61-25.46;P=0.006) and below cutoff FMD (<3.3%) and below cutoff nitroglycerine-induced vasodilation (<11.6%; hazard ratio, 7.20; 95% confidence interval, 2.37-31.36;P<0.001) remained strong independent indicator of cardiovascular events. These findings suggest that the combination of FMD and nitroglycerine-induced vasodilation measurements can more accurately predict cardiovascular events compared with FMD alone. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: UMIN000001167.Entities:
Keywords: atherosclerosis; biomarkers; cardiovascular diseases; endothelium; myocardial infarction
Mesh:
Substances:
Year: 2016 PMID: 26975705 DOI: 10.1161/HYPERTENSIONAHA.115.06839
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190